Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Leonor Barroso"'
Autor:
Ilda P. Ribeiro, Francisco Marques, Leonor Barroso, Jorge Miguéis, Francisco Caramelo, André Santos, Maria J. Julião, Joana B. Melo, Isabel M. Carreira
Publikováno v:
Molecular Cytogenetics, Vol 10, Iss 1, Pp 1-9 (2017)
Abstract Background The choice of therapeutic modality for oral carcinoma in recurrent or second primary tumors remains controversial, as the treatment modalities available might be reduced by the treatment of the first tumor, and the overall surviva
Externí odkaz:
https://doaj.org/article/d2d2e095cd334a5384d6549094e7b322
Autor:
Inês Santos, João Ferreira de Barros, Teresa Lopes, Isabel Amado, Leonor Barroso, Margarida Mesquita
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Bronchogenic cysts are rare foregut duplications cysts. • Mostly diagnosed in children, they may be found in elder patients. • Neck bronchogenic cysts, albeit unusual, should be considered in the differential diagnosis of cystic ma
Autor:
Ilda Patrícia Ribeiro, Isabel M. Carreira, Rui Costa, Leonor Barroso, Nicole Pedro, Teresa Lopes, Fernando Ribeiro
Publikováno v:
Oral oncology. 124
Autor:
Ilda Patrícia Ribeiro, Isabel M. Carreira, Leonor Barroso, Luísa Esteves, Francisco Batel Marques, Ana C. Santos, Francisco Caramelo, Joana B. Melo
Publikováno v:
Oncogene. 40(22)
The prognosis of oral squamous cell carcinoma (OSCC) patients remains poor without implemented biomarkers in the clinical routine practice to help in the patient's management. With this study we aimed to identify specific prognostic biomarkers for OS
Autor:
Isabel M. Carreira, Ilda Patrícia Ribeiro, Leonor Barroso, Joana Menoita, Francisco Caramelo, Francisco Batel Marques, Jorge Miguéis, Joana B. Melo, Luísa Esteves
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Scientific Reports
Scientific Reports
The head and neck squamous cell carcinoma (HNSCC) population consists mainly of high-risk for recurrence and locally advanced stage patients. Increased knowledge of the HNSCC genomic profile can improve early diagnosis and treatment outcomes. The dev
Autor:
Ilda Patrícia Ribeiro, Isabel M. Carreira, Francisco Batel Marques, Joana B. Melo, Leonor Barroso, Joana Rodrigues, Francisco Caramelo
Publikováno v:
Molecular Medicine Reports
Oral leukoplakia and erythroleukoplakia are common oral potentially malignant disorders diagnosed in the oral cavity. The specific outcome of these lesions remains to be elucidated, as their malignant transformation rate exhibits great variation. The
Publikováno v:
BMJ Case Rep
Eagle Syndrome (ES), also termed stylohyoid syndrome or styloid syndrome, is a rare condition characterised by a cluster of symptoms related to an elongation of the styloid process (SP) of the temporal bone. These may range from mild pharyngeal forei
Autor:
Luísa Esteves, Francisco Caramelo, Isabel M. Carreira, Ilda Patrícia Ribeiro, Joana B. Melo, Leonor Barroso, Camila Oliveira, Francisco Batel Marques
Publikováno v:
Journal of Cancer
Purpose: Although oral squamous cell carcinoma (OSCC) presents great mortality and morbidity worldwide, the mechanisms behind its clinical behavior remain unclear. Biomarkers are needed to forecast patients' survival and, among those patients undergo
Autor:
Ilda Patrícia Ribeiro, Isabel M. Carreira, Francisco Caramelo, André Santos, Joana B. Melo, Leonor Barroso, Maria José Julião, Francisco Batel Marques
Publikováno v:
Current problems in cancer. 41(6)
The tongue is the most common and aggressive site for tumors in the oral cavity. These tumors are usually located in the lateral border of the tongue and are often related to the use of tobacco and alcohol. Clinical management of these tumors is pred
Autor:
Margarida Mesquita, Leonor Barroso, Ilda Patrícia Ribeiro, Maria José Julião, Hugo Prazeres, Francisco Caramelo, Isabel Poiares Baptista, Francisco Batel Marques, Isabel M. Carreira, Ana Domingues, Joana B. Melo, Artur Ferreira
Publikováno v:
Cellular oncology (Dordrecht). 39(6)
Oral squamous cell carcinoma (OSCC) is a frequently occurring aggressive malignancy with a heterogeneous clinical behavior. Based on the paucity of specific early diagnostic and prognostic biomarkers, which hampers the appropriate treatment and, ulti